© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 23, 1876-1878,
December 6, 2000
© 2000 Oxford University Press
NEWS |
Childrens Oncology Group Looks to Increase Efficiency, Numbers in Clinical Trials
To many, the announced merger of four pediatric cancer clinical trials cooperative groups more than 2 years ago was long overdue. The leaders of the groups for the most part agreed that the time was right to form a new entity, which they dubbed the Childrens Oncology Group. Together, rather than separately, they said, they could cut research duplication, better use dwindling funds, and increase clinical study efficiency. The marriage of talent and resources had the blessing even the urgingof the National Cancer Institute, the groups main funding agency.
In the old system, institutions conducting pediatric clinical trials belonged to either the Childrens Cancer Group or the Pediatric Oncology Group. Member institutions then might participate in trials conducted by two other groups, the Intergroup Rhabdomyosarcoma Study Group and the National Wilms
Competition
No One Voice
Challenges Ahead
Merger Has Benefits
Peer Review Logistics